Study to Assess the Safety and Pharmacokinetics of TPOXX ® When Administered Orally for 28 Days
Condition: Smallpox Interventions: Biological: JYNNEOS + TPOXX; Biological: JYNNEOS + TPOXX PLACEBO Sponsors: SIGA Technologies; Biomedical Advanced Research and Development Authority Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 12, 2021 Category: Research Source Type: clinical trials